Assessing Salivary Maresins and Protectins Response to gum treatment in Participants with gum and alveolar bone disease, with and without Type 2 Diabetes: An Observational Study
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2024/04/065414
- Lead Sponsor
- Kishore STR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients of both genders and age group 35-65 years.
2.Patients with Stage II and stage III generalised periodontitis with
interdental clinical attachment loss = 3mm.
3.Control group (systemically healthy periodontitis patients)
4.Test group ( periodontitis patients with type 2 diabetes mellitus with
HbA1c = 6.5%).
5.Patients with more than 20 teeth .
6.Patients who are complying with oral hygiene instructions and
periodontal recall.
7.Patients who are willing to participate in the study.
1.Pregnant and lactating women.
2.Patients using medication affecting the periodontal status.
3.Patients with history of periodontal therapy for the past six months.
4.Patients with immunodeficiency disorders and other inflammatory
conditions like inflammatory bowel disorders, inflammatory
rheumatoid disorders, cancers, COPD will be excluded from the study.
5.Patient with the habit of smoking and chewing / other oral lesions such
as periodontal abscess are not to be included.
6.History of radiation therapy to the head and neck
7.Patients who are not willing to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method